LianBio

LIANYOTCHealthcare● Active

$0.11

+$0.00(+0.00%)

Market Cap$12025709

P/E Ratio—

52W High$0.439

52W Low$0.03

Avg Volume45K

Open$0.11

Beta0.04

Earnings Financials Revenue

LianBio (LIANY) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LIANY · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2024Report Date: Mar 25, 2024

EPS Actual

$3.55

Est. -$0.19 · +1968.4%

Revenue

—

Fiscal Period

Q1 FY2024

FY ends December

Report Date

Mar 25, 2024

After Market Close

▲ Beat EPS✓ 3-Quarter EPS Beat Streak

LIANY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 18, 2026	-$0.57	—	—	—	—	—
◌ Q2 FY2026	May 15, 2026	-$0.57	—	—	—	—	—
◌ Q2 FY2026	May 15, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 23, 2026	-$0.57	—	—	—	—	—
◌ Q2 FY2025	Apr 25, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 28, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Nov 18, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Aug 9, 2024	-$0.09	—	—	—	—	—

Q3 FY2026

Aug 18, 2026

EPS Actual

—

EPS Est.

-$0.57

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 15, 2026

EPS Actual

—

EPS Est.

-$0.57

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 15, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 23, 2026

EPS Actual

—

EPS Est.

-$0.57

EPS Surpr.

—

Revenue

—

Q2 FY2025

Apr 25, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 28, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Nov 18, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 9, 2024

EPS Actual

—

EPS Est.

-$0.09

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2029	$-0.09	$-0.09	$-0.09	1
Q2 FY2029	$-0.09	$-0.09	$-0.09	1
Q1 FY2029	$-0.09	$-0.09	$-0.09	1
Q4 FY2028	$-0.09	$-0.09	$-0.09	1
Q3 FY2028	$-0.19	$-0.19	$-0.19	1
Q2 FY2028	$-0.33	$-0.33	$-0.33	1

Revenue Estimates

Period	Low	Consensus	High
Q3 FY2029	$0.0B	$0.0B	$0.0B
Q2 FY2029	$0.0B	$0.0B	$0.0B
Q1 FY2029	$0.0B	$0.0B	$0.0B
Q4 FY2028	$0.0B	$0.0B	$0.0B
Q3 FY2028	$0.0B	$0.0B	$0.0B
Q2 FY2028	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q1 FY2024	Mar 25, 2024	+1968.4%	$0.31	$0.31	+0.16%
▲ Q3 FY2023	Sep 30, 2023	+32.0%	$1.49	$1.46	-2.01%
▲ Q2 FY2023	Jun 30, 2023	+30.0%	$2.37	$2.28	-3.80%

Q1 FY2024+0.16%

Report Date

Mar 25, 2024

EPS Beat/Miss

+1968.4%

Price Before

$0.31

Price After

$0.31

Q3 FY2023-2.01%

Report Date

Sep 30, 2023

EPS Beat/Miss

+32.0%

Price Before

$1.49

Price After

$1.46

Q2 FY2023-3.80%

Report Date

Jun 30, 2023

EPS Beat/Miss

+30.0%

Price Before

$2.37

Price After

$2.28

Avg Beat Reaction-1.88%

Beat Rate3 / 3 quarters

Largest Move-3.80% (Q2 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

LianBio (LIANY) most recently reported earnings on March 25, 2024 for Q1 FY2024, posting EPS of $3.55 — beating the analyst consensus of $-0.19 by +1968.4%. LIANY has beaten EPS estimates for 3 consecutive quarters. The next LIANY earnings date is expected around September 1, 2026.

Each quarter, investors track LIANY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LIANY revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

LIANY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

LIANY earnings · 5 questions

LianBio's next earnings report is expected around September 1, 2026. LIANY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LIANY historically reports after market close (AMC).

LIANY earnings datewhen is LIANY earningsLIANY next earnings datewhen does LIANY report earningsLIANY earnings calendar

▸ Source: FMP · LianBio SEC filings · US GAAP · LianBio SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026